Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


14.08.2017

1 Ann Intern Med
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
3 Gastroenterology
3 Hepatology
2 J Hepatol
1 J Med Virol
3 J Viral Hepat
2 J Virol
2 PLoS One
1 Transplantation
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. KATTAKUZHY S, Gross C, Emmanuel B, Teferi G, et al
    Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
    Ann Intern Med. 2017 Aug 8. doi: 10.7326/M17-0118.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  2. YAYA I, Roux P, Marcellin F, Salmon-Ceron D, et al
    Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4703.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  3. MIOTTO N, Mendes LC, Zanaga LP, Goncales ESL, et al
    Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis: results of a real-life cohort.
    Eur J Gastroenterol Hepatol. 2017 Aug 10. doi: 10.1097/MEG.0000000000000944.
    PubMed     Text format     Abstract available


    Gastroenterology

  4. SINGH S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology. 2017;152:1544-1577.
    PubMed     Text format     Abstract available

  5. BOLTE FJ, O'Keefe AC, Webb LM, Serti E, et al
    Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35975.
    PubMed     Text format     Abstract available

  6. YU ML
    Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C.
    Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35886.
    PubMed     Text format    


    Hepatology

  7. NIU Y, Xu M, Slagle BL, Huang H, et al
    Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28924.
    PubMed     Text format     Abstract available

  8. FLEMMING JA, Kim WR, Brosgart CL, Terrault NA, et al
    Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28923.
    PubMed     Text format     Abstract available

  9. TEDESCO D, Thapa M, Gumber S, Elrod EJ, et al
    CD4+ Foxp3+ T cells promote aberrant immunoglobulin G production and maintain CD8+ T-cell suppression during chronic liver disease.
    Hepatology. 2017;65:661-677.
    PubMed     Text format     Abstract available


    J Hepatol

  10. DA SILVA FILIPE A, Sreenu V, Hughes J, Aranday-Cortes E, et al
    Response to DAA Therapy in the NHS England Early Access Programme for Rare HCV Subtypes from Low and Middle Income Countries.
    J Hepatol. 2017 Aug 5. pii: S0168-8278(17)32195.
    PubMed     Text format    

  11. ZEUZEM S, Dvory-Sobol H, Brainard DM
    No Effect Of Resistance-Associated Substitutions In Patients With Rare HCV Subtypes Following Treatment With Sofosbuvir-Containing Regimens.
    J Hepatol. 2017 Aug 5. pii: S0168-8278(17)32191.
    PubMed     Text format    


    J Med Virol

  12. YANG T, Chen Q, Li D, Wang T, et al
    High prevalence of syphilis, HBV and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital.
    J Med Virol. 2017 Aug 9. doi: 10.1002/jmv.24912.
    PubMed     Text format     Abstract available


    J Viral Hepat

  13. VON FELDEN J, Scheurich C, Yamamura J, Brainard DM, et al
    Successful treatment of chronic hepatitis C with ground ledipasvir / sofosbuvir in a patient with Crohn's disease and short bowel syndrome.
    J Viral Hepat. 2017 Aug 7. doi: 10.1111/jvh.12768.
    PubMed     Text format     Abstract available

  14. BARONE M, Iannone A, Shahini E, Ippolito AM, et al
    A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: the ITAL-C network study.
    J Viral Hepat. 2017 Aug 8. doi: 10.1111/jvh.12765.
    PubMed     Text format     Abstract available

  15. MERCHANTE N, Aldamiz-Echevarria T, Garcia-Alvarez M, Rivero-Juarez A, et al
    Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients.
    J Viral Hepat. 2017 Aug 7. doi: 10.1111/jvh.12769.
    PubMed     Text format     Abstract available


    J Virol

  16. KWON YC, Sasaki R, Meyer K, Ray R, et al
    HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS.
    J Virol. 2017 Aug 9. pii: JVI.01235-17. doi: 10.1128/JVI.01235.
    PubMed     Text format     Abstract available

  17. PIERCE BG, Boucher EN, Piepenbrink KH, Ejemel M, et al
    Structure-Based Design of Hepatitis C Virus Vaccines that Elicit Neutralizing Antibody Responses to a Conserved Epitope.
    J Virol. 2017 Aug 9. pii: JVI.01032-17. doi: 10.1128/JVI.01032.
    PubMed     Text format     Abstract available


    PLoS One

  18. NAGAOKI Y, Imamura M, Aikata H, Daijo K, et al
    The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.
    PLoS One. 2017;12:e0182710.
    PubMed     Text format     Abstract available

  19. HUANG CM, Chang KC, Hung CH, Chiu KW, et al
    Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
    PLoS One. 2017;12:e0182204.
    PubMed     Text format     Abstract available


    Transplantation

  20. ABAALKHAIL F, Elsiesy H, Elbeshbeshy H, Shawkat M, et al
    Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant Setting.
    Transplantation. 2017 Aug 9. doi: 10.1097/TP.0000000000001907.
    PubMed     Text format     Abstract available


    Virology

  21. WU Q, Li Z, Liu Q
    Treatment with PTEN-Long protein inhibits hepatitis C virus replication.
    Virology. 2017;511:1-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: